Company Profile

Focused on your needs
A simple, unified Teva offers agile and affordable solutions for patients

Teva is committed to putting people at the center of what we do. By building on our strong global footprint and harnessing our size and scale, we are increasing access to quality health solutions to enable millions of people around the world to live better, healthier days. We do this by developing and producing affordable, high quality generic drugs, innovative specialty pharmaceuticals and active pharmaceutical ingredients.

As a global pharmaceutical leader and the world’s largest generic medicines producer it is our employees who are at the core of our success. We have colleagues in over 60 countries who develop, produce and deliver the world’s largest medicine cabinet to 200 million people every day.

By simplifying and unifying our business, we will meet the needs of our stakeholders and make good on our promise to build a sustainable business. By continually developing our uniquely diverse portfolio of products and solutions we meet the needs of our patients and caregivers, always evolving through research and development in key therapeutic areas, business development and innovation.

We wake up with pride every morning knowing that we enable people to live better days – while ensuring the highest standards of compliance and business integrity in everything we do. This is how we improve health and enable people to live better, healthier lives.

Teva Corporate Video

Many things in life can be counted. At Teva we focus on the things that count. Teva Pharmaceuticals has been developing and producing medicines to improve people’s lives for more than a century. We are a global leader in generic and specialty medicines with a portfolio consisting of over 3,500 different products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day and are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of biopharmaceutical products. Learn more at